AbbVie Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AbbVie Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2012 to Q3 2024.
  • AbbVie Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $181M, a 39.2% increase year-over-year.
  • AbbVie Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $872M, a 15.7% increase year-over-year.
  • AbbVie Inc. annual Share-based Payment Arrangement, Expense for 2023 was $747M, a 11.3% increase from 2022.
  • AbbVie Inc. annual Share-based Payment Arrangement, Expense for 2022 was $671M, a 3.04% decline from 2021.
  • AbbVie Inc. annual Share-based Payment Arrangement, Expense for 2021 was $692M, a 8.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $872M $181M +$51M +39.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $821M $218M +$39M +21.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $782M $348M +$35M +11.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $747M $125M -$7M -5.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $754M $130M +$4M +3.18% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $750M $179M +$72M +67.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $678M $313M +$7M +2.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $671M $132M +$3M +2.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $668M $126M -$9M -6.67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $677M $107M -$52M -32.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $729M $306M +$37M +13.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $692M $129M -$7M -5.15% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $699M $135M -$27M -16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $726M $159M -$77M -32.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $803M $269M +$50M +22.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $753M $136M +$57M +72.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $696M $162M +$87M +116% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $609M $236M +$149M +171% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $460M $219M +$30M +15.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $430M $79M +$9M +12.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $421M $75M $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $421M $87M +$2M +2.35% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $419M $189M -$2M -1.05% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $421M $70M -$7M -9.09% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $428M $75M +$4M +5.63% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $424M $85M +$9M +11.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $415M $191M +$50M +35.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $365M $77M +$3M +4.05% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $362M $71M +$24M +51.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $338M $76M -$61M -44.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $399M $141M +$3M +2.17% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $396M $74M +$21M +39.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $375M $47M -$8M -14.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $383M $137M +$82M +149% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $301M $138M +$19M +16% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $282M $53M +$11M +26.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $271M $55M +$11M +25% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $260M $55M +$6M +12.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $254M $119M +$13M +12.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $241M $42M +$4M +10.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $237M $44M +$3M +7.32% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $234M $49M +$3M +6.52% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $231M $106M +$19M +21.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $212M $38M +$7M +22.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $205M $41M +$11M +36.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $194M $46M +$11M +31.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $183M $87M -$4M -4.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $187M $31M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $30M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $35M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $91M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.